Iris, a Japanese company led by Sho Okuyama, has developed Nodoca, an AI-powered device that analyzes throat images to assess conditions like influenza and COVID-19. This system, which received approval as a new medical device in Japan and is covered by national health insurance, aims to replace uncomfortable nasal swab tests. Nodoca has been implemented in over 2,000 medical institutions and continues to improve its accuracy through accumulated data, with potential applications extending to lifestyle-related diseases. AI
IMPACT Streamlines routine medical diagnostics, potentially reducing patient discomfort and improving early detection of infectious diseases.
RANK_REASON The item describes a specific AI-powered medical device and its market adoption, which falls under the 'tool' category.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →